tiprankstipranks
OptiNose Inc Raises $55 Million to Boost XHANCE Commercialization
Company Announcements

OptiNose Inc Raises $55 Million to Boost XHANCE Commercialization

Pick the best stocks and maximize your portfolio:

Optinose Inc (OPTN) just unveiled an announcement.

OptiNose, Inc. has initiated a Registered Direct Offering, agreeing to sell over 31 million common stock shares and nearly 24 million pre-funded warrants to investors, aiming to raise approximately $55 million. Scheduled to close on May 10, 2024, the proceeds will primarily support working capital and the commercialization of their product, XHANCE. The company has also amended an earlier agreement to facilitate this offering, which includes adjusting the exercise price of existing warrants and issuing new shares to settle amendment fees, further demonstrating their strategic financial management to bolster their market position and fund growth initiatives.

Find detailed analytics on OPTN stock on TipRanks’ Stock Analysis page.

Related Articles
TheFlyOptinose price target lowered to $1 from $3 at Piper Sandler
TipRanks Auto-Generated NewsdeskOptinose Shows Prescription Growth Amid Revenue Challenges
TheFlyOptinose reports Q3 EPS 0c, consensus (5c)
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App